Skip to main content

Table 2 PH drug therapy of all patients before BPA

From: Effects of right ventricular remodeling in chronic thromboembolic pulmonary hypertension on the outcomes of balloon pulmonary angioplasty: a 2D-speckle tracking echocardiography study

PH drug therapy

N (%)

PH targeted therapy

 None

5 (6.58)

 ERA

16 (2.67)

 PDE-5 inhibitors

23 (30.26)

 sGC stimulators

9 (11.84)

 Prostacyclin analogues

8 (10.53)

 CCB

2 (2.63)

Anticoagulation

 None

5 (6.58)

 Warfarin

56 (73.68)

 Rivaroxaban

20 (26.32)

  1. Values are expressed as frequency (percentage)
  2. Abbreviations: PH Pulmonary hypertension, ERA Endothelin receptor antagonists, PDE-5 inhibitors Phosphodiesterase-5 inhibitors, sGC stimulators Soluble guanylate cyclase stimulators, CCB Calcium channel blockers
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us